Placebo News and Research

RSS

Study: Psoriasis patients taking Humira show no change in aortic inflammation

An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation – a key marker of future risk of major cardiovascular events – unlike other antibodies that target different aspects of the immune system.

18 May 2018

Guideline revisions for knee osteoarthritis have 'subtle but significant' impact on clinical practice

Recent updates in evidence-based recommendations have led to changes in the use of steroid and hyaluronic acid injection for patients with osteoarthritis of the knee, reports a study in the May 16, 2018 issue of The Journal of Bone & Joint Surgery.

18 May 2018

Clot busting drug combo reduces risk of major strokes in high risk patients

In patients who have had a minor stroke or a transient ischemic stroke (TIA), the risk of getting a full-blown stroke or a major stroke is high. A new study has found that these high-risk individuals, when prescribed with clot-preventing drugs clopidogrel along with aspirin show a lower risk of getting major stroke.

18 May 2018

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms

The United States Food and Drugs Administration (FDA), in a statement this week, approved a new drug Lucemyra (lofexidine hydrochloride) for the treatment and alleviation of opioid symptom withdrawal symptoms in adults in whom the drugs have been withdrawn abruptly.

17 May 2018

Sleep deprivation study to pinpoint brain processes causing poor decision-making

Sleep deprivation can take a heavy toll on our ability to make sound decisions, with potentially disastrous outcomes.

17 May 2018

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.

17 May 2018

International study finds viable treatment option for people with mild asthma

A large international study led by a Hamilton researcher has found a patient-centric treatment that works for people with mild asthma.

17 May 2018

Study finds molecular handle that chikungunya virus uses to enter into cells and cause arthritis

Chikungunya virus is a growing threat to the United States and other regions of the world as the mosquito that carries the virus expands its reach. Telltale symptoms of chikungunya infection are fever and joint pain that last about a week.

17 May 2018

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

17 May 2018

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

The research was part of the Platelet-Oriented Inhibition in New TIA and minor ischemic stroke trial -- a randomized, double-blind, placebo-controlled trial conducted between May 2010 and December 2017.

16 May 2018

Study: Drug used to treat blood loss may be beneficial for some stroke patients

Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth, an international trial has revealed.

16 May 2018

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.

14 May 2018

Human papilloma virus vaccines can protect against cervical lesions in young women

New evidence published today in the Cochrane Library shows that human papilloma virus vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26.

9 May 2018

Study compares effectiveness of vaginal estradiol tablets and moisturizers in treating vulvovaginal problems

A new study reports that vaginal estradiol tablets just might be what's needed to relieve vulvovaginal problems and improve overall quality of life.

9 May 2018

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

Erythropoietin helps to protect and repair vulnerable brains though it remains a mystery how the anemia drug does so.

7 May 2018

Phase 2 clinical study of universal influenza vaccine begins in the United States

A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States.

4 May 2018

Maternal placentophagy does not cause harm to newborn babies, study finds

The largest study of its kind found mothers who consumed their placenta passed on no harm to their newborn babies when compared to infants of mothers who did not consume their placenta.

3 May 2018

Brain stimulation may offer new way to prevent suicide in people with hard-to-treat depression

A specific kind of brain stimulation is effective in reducing suicidal thinking in a significant portion of people with hard-to-treat depression, according to a new CAMH study published in The Journal of Clinical Psychiatry.

3 May 2018

Nonsteroidal anti-inflammatory drug ranked to be most effective in treating knee OA

An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.

2 May 2018

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

A new experimental study has tested the safety and effectiveness of MDMA-assisted psychotherapy in 26 service personnel with post-traumatic stress disorder (PTSD).

2 May 2018

Placebo News and Research

Study: Psoriasis patients taking Humira show no change in aortic inflammation

Guideline revisions for knee osteoarthritis have 'subtle but significant' impact on clinical practice

Clot busting drug combo reduces risk of major strokes in high risk patients

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms

Sleep deprivation study to pinpoint brain processes causing poor decision-making

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

International study finds viable treatment option for people with mild asthma

Study finds molecular handle that chikungunya virus uses to enter into cells and cause arthritis

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

Study: Drug used to treat blood loss may be beneficial for some stroke patients

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Human papilloma virus vaccines can protect against cervical lesions in young women

Study compares effectiveness of vaginal estradiol tablets and moisturizers in treating vulvovaginal problems

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

Phase 2 clinical study of universal influenza vaccine begins in the United States

Maternal placentophagy does not cause harm to newborn babies, study finds

Brain stimulation may offer new way to prevent suicide in people with hard-to-treat depression

Nonsteroidal anti-inflammatory drug ranked to be most effective in treating knee OA

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News